Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...

Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

The focus of the lawsuit is forfeited funds, which total the amount of employer match contributions participants lose if they ...

Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

The stock's fall snapped a five-day winning streak.

The health insurer is accused of using forfeited funds from departing employees to reduce employer contributions to the ...

The Cigna Group is the latest company accused of mismanaging the forfeited funds in its 401(k) plan, and software company ...